Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
MDI-2268
AOB17684
CAS: 1609176-50-2
Chemical Name: 2-Hydrazineyl-2-oxo-N-(3-(trifluoromethoxy)benzyl)acetamide
AOBIOUS launched this product in 2019
Citation (Publications used AOBIOUS products):
276 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $31.45 | Total: $157.25 |
| 1 | 10 | $26.64 | Total: $266.40 |
| 1 | 25 | $22.57 | Total: $564.25 |
| 1 | 50 | $19.24 | Total: $962.00 |
| 1 | 100 | $16.65 | Total: $1,665.00 |
Overview
Novel potent inhibitor of plasminogen activator inhibitor type-1 (PAI-1)
Chemical Properties
| Molecular Formula | C10H10F3N3O3 |
| Molecular Weight | 277.20 |
| CAS Numbers | 1609176-50-2 |
| Solubility | DMSO and Water |
| Purity | 99% (HPLC) |
| IUPAC/Chemical Name | 2-Hydrazineyl-2-oxo-N-(3-(trifluoromethoxy)benzyl)acetamide |
| InChl Key | RONKZYYGLIORQV-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C10H10F3N3O3/c11-10(12,13)19-7-3-1-2-6(4-7)5-15-8(17)9(18)16-14/h1-4H,5,14H2,(H,15,17)(H,16,18) |
| SMILES Code | O=C(NCC1=CC=CC(OC(F)(F)F)=C1)C(NN)=O |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
Synonyms
MDI-2268; MDI 2268; MDI2268
References
Reinke AA, Li SH, Warnock M, Shaydakov ME, Guntaka NS, Su EJ, Diaz JA, Emal CD, Lawrence DA. Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate. J Biol Chem. 2019 Feb 1;294(5):1464-1477
